Dragonfly Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership

Chinese pharma companies, more established drug makers and biotech start-ups alike, are increasingly looking to license out rights to their product candidates to global partners in an effort to weathe

Having successfully partnered Nubeqa with a pharma major in Bayer AG , Orion Corporation has teamed up with an even bigger player, Merck & Co., Inc. , for another prostate cancer candidate, pickin